Jupiter Neurosciences faces delisting from Nasdaq Capital Market after its listed securities stayed below the required $35,000,000 threshold, although its common stock regained the $1.00 per-share bid-price standard. The company plans to appeal, but continued listing and successful relief remain uncertain for investors.

Key Highlights

  • The common stock met Nasdaq’s $1.00 per-share bid-price requirement from August 13 through August 26.
  • Jupiter expects a hearing request to stay further Nasdaq action pending a final panel decision.
  • Nasdaq’s deadline for Jupiter to regain compliance with its market-value requirement was August 25.

JUPITER NEUROSCIENCES, INC. (NASDAQ: JUNS) faces delisting from the Nasdaq Capital Market after its listed securities remained below the required $35,000,000 market-value threshold. Nasdaq’s staff also determined that Jupiter had not met alternative continued-listing requirements, even as the common stock restored compliance with the $1.00 minimum bid-price standard.

$35,000,000 Market-Value Requirement Remains Unmet

Nasdaq’s Listing Qualifications Department notified Jupiter on August 27 that the market-value requirement had not been restored. The staff had previously informed the company on February 26 that its listed securities were below $35,000,000 for consecutive trading days and gave it until August 25 to regain compliance. Nasdaq also determined that Jupiter had not satisfied the alternative requirements under its continued-listing rules.

A separate letter confirmed that the common stock’s closing bid price was at least $1.00 per share from August 13 through August 26, closing that matter.

Hearing Request Could Pause Further Delisting Action

Jupiter intends to seek a hearing before the Nasdaq Hearings Panel to appeal the delisting decision. The company expects that requesting the hearing will stay further action while the panel considers the matter. Nasdaq’s staff cautioned that the appeal may not succeed and that the panel may not grant continued listing or relief from delisting.

Jupiter is considering all available Options to regain compliance with the applicable listing rules.

Peers Moving on This News